相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo
Wolfgang Jacob et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2012)
FEAR RELIEF-TOWARD A NEW CONCEPTUAL FRAME WORK AND WHAT ENDOCANNABINOIDS GOTTA DO WITH IT
C. J. Riebe et al.
NEUROSCIENCE (2012)
CB1 receptor antagonists: new discoveries leading to new perspectives
E. Kirilly et al.
Acta Physiologica (2011)
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naive Social Phobia Patients
Mateus M. Bergamaschi et al.
NEUROPSYCHOPHARMACOLOGY (2011)
National Science and Technology Institute for Translational Medicine (INCT-TM): advancing the field of translational medicine and mental health
Jaime E. C. Hallak et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2010)
The Fast Alcohol Screening Test (FAST) is as Good as the AUDIT to Screen Alcohol Use Disorders
Carolina Meneses-Gaya et al.
SUBSTANCE USE & MISUSE (2010)
Adverse health effects of non-medical cannabis use
Wayne Hall et al.
LANCET (2009)
Study of the Discriminative Validity of the PHQ-9 and PHQ-2 in a Sample of Brazilian Women in the Context of Primary Health Care
Flavia de Lima Osorio et al.
PERSPECTIVES IN PSYCHIATRIC CARE (2009)
The psychiatric side-effects of rimonabant
Fabricio A. Moreira et al.
REVISTA BRASILEIRA DE PSIQUIATRIA (2009)
Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats
J. Haller et al.
PSYCHOPHARMACOLOGY (2009)
Acute administration of the cannabinoid CB1 antagonist rimonabant impairs positive affective memory in healthy volunteers
Jamie Horder et al.
PSYCHOPHARMACOLOGY (2009)
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
Fabricio A. Moreira et al.
NEUROPHARMACOLOGY (2008)
Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials
Robin Christensen et al.
LANCET (2007)
Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users
Marilyn A. Huestis et al.
PSYCHOPHARMACOLOGY (2007)
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality
Pattipati S. Naidu et al.
PSYCHOPHARMACOLOGY (2007)
Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: Further evidence for an anxiolytic role for endogenous cannabinoid signaling
Sachin Patel et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers
DA Gorelick et al.
AMERICAN HEART JOURNAL (2006)
Endocannabinoid system and stress and anxiety responses
MP Viveros et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice
J Haller et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Monitoring depression treatment outcomes with the patient health questionnaire-9
B Löwe et al.
MEDICAL CARE (2004)
Modulation of anxiety through blockade of anandamide hydrolysis
S Kathuria et al.
NATURE MEDICINE (2003)
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
AC Howlett et al.
PHARMACOLOGICAL REVIEWS (2002)
The Fast Alcohol Screening Test
R Hodgson et al.
ALCOHOL AND ALCOHOLISM (2002)
Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716
MA Huestis et al.
ARCHIVES OF GENERAL PSYCHIATRY (2001)
Psychometric properties of the Social Phobia Inventory (SPIN) - New self-rating scale
KM Connor et al.
BRITISH JOURNAL OF PSYCHIATRY (2000)
分享论文
